企业版公测上线啦!点击立即查看
登录 注册
当前位置: 首页 > FDA历年批准NMEs及Biologics 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
药品名称 批准类型 活性成分 适应症 上市发布公告 临床试验快照 批准日期 申请机构
Xpovio NME selinexor To treat adult patients with relapsed or refractory multiple myeloma (RRMM) Press Release 2019/07/03 KARYOPHARM THERAPEUTICS INC
Polivy Biologics polatuzumab vedotin-piiq To treat adult patients with relapsed or refractory diffuse large B-cell lymphoma Press Release 2019/06/10 GENENTECH
Piqray NME alpelisib To treat breast cancer Press Release Drug Trials Snapshot 2019/05/24 NOVARTIS PHARMS CORP
Vyndaqel NME tafamidis meglumine To treat heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults Press Release  Drug Trials Snapshot 2019/05/03 FOLDRX PHARMS
Skyrizi Biologics risankizumab-rzaa To treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Drug Trials Snapshot 2019/04/23 ABBVIE INC
Balversa NME erdafitinib To treat adult patients with locally advanced or metastatic bladder cancer Press Release Drug Trials Snapshot 2019/04/12 JANSSEN BIOTECH
Evenity Biologics romosozumab-aqqg To treat osteoporosis in postmenopausal women at high risk of fracture Press Release Drug Trials Snapshot 2019/04/09  AMGEN INC
Mayzent NME siponimod To treat adults with relapsing forms of multiple sclerosis Press Release Drug Trials Snapshot 2019/03/26  NOVARTIS PHARMS CORP
Sunosi NME solriamfetol To treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea Drug Trials Snapshot 2019/03/20  JAZZ
Zulresso NME brexanolone To treat postpartum depression (PPD) in adult women Press Release Drug Trials Snapshot 2019/03/19 SAGE THERAP
Egaten NME triclabendazole To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” Drug Trials Snapshot 2019/02/13 NOVARTIS PHARMS CORP
Cablivi Biologics caplacizumab-yhdp To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) Press Release Drug Trials Snapshot 2019/02/06 ABLYNX NV
JEUVEAU Biologics PRABOTULINUMTOXINA-XVFS For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients Drug Trials Snapshot 2019/02/01 EVOLUS INC
Ibsrela NME tenapanor To treat irritable bowel syndrome with constipation in adults. 2019-09-12 ARDELYX INC
Nourianz NME istradefylline To treat adult patients with Parkinson’s disease experiencing “off” episodes Press Release 2019-08-27 KYOWA KIRIN
Ga-68-DOTATOC NME Ga-68-DOTATOC For use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) Drug Trials Snapshot 2019-08-21 UNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER
Xenleta NME lefamulin To treat adults with community-acquired bacterial pneumonia Press Release Drug Trials Snapshot 2019-08-19 NABRIVA THERAPEUTICS US INC
Rinvoq NME upadacitinib To treat adults with moderately to severely active rheumatoid arthritis Drug Trials Snapshot 2019-08-16 ABBVIE INC
Inrebic NME fedratinib To treat adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis Press Release Drug Trials Snapshot 2019-08-16 IMPACT BIOMEDICINES INC
Rozlytrek NME entrectinib To treat adult and pediatric patients 12 years of age and older with solid tumors Press Release Drug Trials Snapshot 2019-08-15 GENENTECH INC